SCD and breast carcinoma: Moreover, in human lung and breast cancer cells, the inhibition of SCD1 with CVT-11127 promoted the activation of AMP-activated kinase (AMPK) and the reduction of ACC activity, suggesting that SCD1 may regulate FA biosynthesis by controlling the activation of AMPK, which, in turn, phosphorylates ACC-reducing lipogenesis.